# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Vapendavir | 6, BTA798 | Activity | 0 | ALA2065746 | Non-toxic | Homo sapiens | |||||
2. | Vapendavir | 6, BTA798 | Activity | 0 | ALA2065745 | Non-toxic | Homo sapiens | |||||
3. | Vapendavir | 6, BTA798 | AUC | = | 13758 | ng.hr/ml | ALA2065744 | ng.hr.mL-1 | Homo sapiens | |||
4. | Vapendavir | 6, BTA798 | t1/2 | = | 11.8 | hr | ALA2065743 | hr | Homo sapiens | |||
5. | Vapendavir | 6, BTA798 | Tmax | = | 1.03 | hr | ALA2065742 | hr | Homo sapiens | |||
6. | Vapendavir | 6, BTA798 | Cmax | = | 1890 | ng/ml | ALA2065741 | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | nM | Homo sapiens | ||
7. | Vapendavir | 6, BTA798 | t1/2 | = | 15.9 | hr | ALA2065740 | hr | Canis lupus familiaris | |||
8. | Vapendavir | 6, BTA798 | AUC | = | 121000 | ng.hr/ml | ALA2065739 | ng.hr.mL-1 | Canis lupus familiaris | |||
9. | Vapendavir | 6, BTA798 | Tmax | = | 7.7 | hr | ALA2065738 | hr | Canis lupus familiaris | |||
10. | Vapendavir | 6, BTA798 | Cmax | = | 6100 | ng/ml | ALA2065737 | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | nM | Canis lupus familiaris | ||
11. | Vapendavir | 6, BTA798 | t1/2 | = | 18.3 | hr | ALA2065736 | hr | Canis lupus familiaris | |||
12. | Vapendavir | 6, BTA798 | AUC | = | 202000 | ng.hr/ml | ALA2065735 | ng.hr.mL-1 | Canis lupus familiaris | |||
13. | Vapendavir | 6, BTA798 | Tmax | = | 14.7 | hr | ALA2065734 | hr | Canis lupus familiaris | |||
14. | Vapendavir | 6, BTA798 | Cmax | = | 11000 | ng/ml | ALA2065733 | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | nM | Canis lupus familiaris | ||
15. | Vapendavir | 6, BTA798 | F | = | 95 | % | ALA2065732 | % | Rattus norvegicus | |||
16. | Vapendavir | 6, BTA798 | t1/2 | = | 46.4 | hr | ALA2065731 | hr | Rattus norvegicus | |||
17. | Vapendavir | 6, BTA798 | AUC | = | 489000 | ng.hr/ml | ALA2065730 | ng.hr.mL-1 | Rattus norvegicus | |||
18. | Vapendavir | 6, BTA798 | Tmax | = | 11.2 | hr | ALA2065680 | hr | Rattus norvegicus | |||
19. | Vapendavir | 6, BTA798 | Cmax | = | 17700 | ng/ml | ALA2065679 | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | nM | Rattus norvegicus | ||
20. | Vapendavir | 6, BTA798 | F | = | 94 | % | ALA2065678 | % | Rattus norvegicus |